Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimervax (PHH-1V) Booster in Immunosuppressed Adults
NCT05303402Phase 3Completed
- Sponsor
- HIPRA
- Start
- May 2022
- Primary completion
- Jul 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of PHH-1V in coronavirus disease 2019 (COVID-19), sponsored by HIPRA. Started May 2022; status: completed.
02
Drugs
PHH-1V
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05303402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05303402.